Clinical Trials on Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy in Canada
Total 186 results
-
Agensys, Inc.CompletedCarcinoma, Renal Cell | Renal Cell Carcinoma of Papillary Histology | Renal Cell Carcinoma With Clear Cell Histology | Renal Cell Carcinoma With Non-Clear Cell HistologyUnited States, Canada
-
Millennium Pharmaceuticals, Inc.CompletedClear-cell Metastatic Renal Cell CarcinomaSpain, Czechia, United States, Canada, Italy, United Kingdom, France, Poland
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerCanada
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell CarcinomaUnited States, France, Canada, Spain, Italy, Belgium, Austria, Denmark, Germany, Australia, Israel, Russian Federation, Czechia, Norway, Poland, Romania, Japan, Argentina, Ireland, Greece, United Kingdom, Brazil, Sweden, Finland
-
University Health Network, TorontoCompleted
-
Lawson Health Research InstituteHamilton Health Sciences Corporation; London Health Sciences CentreCompletedClear Cell Renal Cancer | Circulating Tumor Cells | Predictive Biomarkers | Prognostic Biomarkers | Circulating Endothelial CellsCanada
-
Sunnybrook Health Sciences CentrePfizerCompletedClear Cell, Metastatic Renal Cell CarcinomaCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Clear Cell Sarcoma of the Kidney | Papillary Renal Cell Carcinoma | Rhabdoid Tumor of the Kidney | Stage I Renal Cell Cancer | Childhood Renal Cell Carcinoma | Stage II Renal Cell Cancer | Stage I Renal Wilms Tumor and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedRenal Cell Carcinoma | Clear-cell Metastatic Renal Cell CarcinomaUnited States, Canada
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedRenal Cell Carcinoma (RCC) | Alveolar Soft Part Sarcoma (ASPS) | Clear Cell Sarcoma (CCS)United States, Canada, United Kingdom
-
Sunnybrook Health Sciences CentrePfizerCompletedClear Cell Metastatic Renal Cell CarcinomaCanada
-
Telix International Pty LtdCompletedClear Cell Renal Cell CarcinomaUnited Kingdom, United States, Australia, Turkey, Netherlands, Belgium, Canada, France
-
Duke UniversityNovartis; PfizerCompletedAdvanced Non-clear Cell Renal Cell CarcinomaUnited States, Canada, United Kingdom
-
Bristol-Myers SquibbOno Pharma USA IncCompletedRenal Cell CarcinomaUnited States, Canada, Italy, Finland
-
MedImmune LLCCompletedKidney Cancer | Clear Cell Renal Cell Carcinoma | Select Advanced MalignanciesUnited States, France, Canada, United Kingdom, Netherlands, Australia
-
ElyptaRecruitingClear Cell Renal Cell CarcinomaUnited States, Sweden, United Kingdom, France, Denmark, Finland, Canada, Italy, Portugal, Spain
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group...CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage II Renal Cell Cancer AJCC v7 | Stage I Renal Cell Cancer AJCC v6 and v7United States, Canada, Puerto Rico
-
National Cancer Institute (NCI)CompletedRecurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Endometrial Clear Cell Carcinoma | Endometrial Papillary Serous Carcinoma | Stage IIIA Endometrial Carcinoma | Stage IIIB Endometrial Carcinoma | Stage IIIC Endometrial Carcinoma | Stage IVA Endometrial Carcinoma | Stage IVB Endometrial... and other conditionsCanada
-
Centre hospitalier de l'Université de Montréal...Bristol-Myers SquibbActive, not recruitingMelanoma | Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Brain Metastases, Adult | Clear-Cell Metastatic Renal Cell CarcinomaCanada
-
University of British ColumbiaRecruitingTransitional Cell Cancer of the Renal Pelvis and Ureter | Urothelial Carcinoma of the Renal Pelvis and UreterCanada
-
PfizerInternational Metastatic Renal Cell Carcinoma Database Consortium (IMDC); Analysis...CompletedMetastatic Renal Cell CarcinomaCanada
-
PfizerAnalysis Group; IMDC groupCompletedMetastatic Renal Cell Carcinoma (mRCC)Canada
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, Renal CellUnited States, Colombia, Canada, Australia, Finland, Japan, United Kingdom, Brazil, Chile, China, Croatia, Czechia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Malaysia, Mexico, Norway, Philippines, Polan... and more
-
National Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Lung Carcinoid Tumor | Stage IV Renal Cell Cancer | Recurrent Digestive System Neuroendocrine Tumor G1 | Adult Solid Neoplasm | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma and other conditionsCanada
-
PfizerTerminatedMetastatic Renal Cell CarcinomaPanama
-
Women's Cancer Care Associates, LLCCompletedEndometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IIIC Uterine Corpus Cancer | Stage IVA Uterine Corpus CancerUnited States, Canada
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerCanada
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Endometrial Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Stage IV Endometrial Carcinoma | Stage III Endometrial Carcinoma | Endometrial Papillary Serous CarcinomaCanada
-
Spanish Oncology Genito-Urinary GroupCompletedMetastatic Renal Cell CarcinomaSpain
-
AstraZenecaSCRI Development Innovations, LLCCompletedPapillary Renal Cell CancerUnited States, Canada, United Kingdom, Spain
-
MacroGenicsTerminatedMelanoma | Soft Tissue Sarcoma | Clear Cell Renal Cell Carcinoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Mesothelioma | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Colon Cancer | Thyroid CancerUnited States, Australia, Canada
-
Sunnybrook Health Sciences CentreMerck Sharp & Dohme LLC; Ozmosis Research Inc.CompletedStage IV Renal Cell Cancer AJCC V7Canada
-
Lawson Health Research InstituteCompletedRenal Cell CarcinomaCanada
-
St. Joseph's Healthcare HamiltonNovartis Pharmaceuticals; McMaster UniversityCompletedCarcinoma, Renal CellCanada
-
St. Joseph's Healthcare HamiltonPfizer; McMaster UniversityCompletedRenal Cell CarcinomaCanada
-
University Health Network, TorontoLantheus Medical ImagingCompleted
-
University Health Network, TorontoPfizerTerminated
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Canada
-
AstraZenecaActive, not recruitingMelanoma | Cervical Cancer | Small Cell Lung Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumours | Non-Small-Cell Lung Cancer | Gastroesophageal Cancer | Clear Cell Renal Cell Cancer | Squamous Cell Cancer of Head and NeckUnited States, Spain, Canada, France
-
University Health Network, TorontoAstraZenecaWithdrawnRenal Cell Carcinoma | Non Small Cell Lung CancerCanada
-
University Health Network, TorontoTerminatedRenal Cell Carcinoma | Partial NephrectomyCanada
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
Kim ChiWyeth is now a wholly owned subsidiary of PfizerWithdrawn
-
Argos TherapeuticsTerminatedRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaIsrael, Spain, United States, Czechia, Canada, Italy, Hungary, United Kingdom
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Lawson Health Research InstituteCompletedTransitional Cell Carcinoma | Renal Cell Cancer | Testicular CancerCanada
-
Eli Lilly and CompanyCompletedMetastatic Renal Cell CancerUnited States, Canada
-
University Health Network, TorontoTerminatedRenal Cell CarcinomaCanada